TSPAN9 and neoplasm: Thirdly, our results suggested that TSPAN9 may play its tumor-suppressor role by reducing tumor immunocyte infiltration, enrichment of immune-related signaling pathway, and expression of immune checkpoint proteins in HCC patients.